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Background
Despite the great advances in developing and implement-
ing effective interventions to prevent HIV transmission
from infected mothers to their infants, almost 2,000
infants are infected every day through MTCT in resource-
poor countries. In these settings, where prevention of
mother to child transmission of HIV-1 (PMTCT) pro-
grams are in place, the uptake and effectiveness of the
PMTCT comprehensive program need to be regularly
monitored.
Main objective
To estimate the field efficacy of a district-wide PMTCT pro-
gramme, in Phnom Penh and Kandal province.
Methods
Six maternity units were included: five in Phnom Penh
(NMCHC, Daun Penh HC, Tuol Kork HC, Pochentong
HC) and one in CCH Takhmao, Kandal Province. Individ-
ual and group counseling were conducted. Prenatal HIV
testing were performed using rapid tests. HAART, or pre-
ventive ARV drugs, were administrated to the mothers and
children according to the national recommendations.
Diagnosis of HIV infection in babies (heel prick blood
spotted on DBS and/or EDTA blood specimen) was done
at the Pasteur Institute of Cambodia by mean of HIV-1
DNA or RNA real time PCR (ANRS kits).
Results
From March 2006 to December 2008, 38,398 pregnant
women visited the ANC (total number of ANC attendees
= 117,739). 33,811 (88%) accepted pre-test counseling
and 33.436 (98%) the HIV testing. 28.236 received post-
test counseling (84%). Finally 320 women joint the
PMTCT programme and 215 delivered. 201 (93,48%)
received an effective PMTCT intervention. Eighty-eight
received HAART (3TC+d4T+NVP) during pregnancy.
Zidovudine (AZT) was provided antenatally from week 28
of gestation and during labour with single dose of Nevi-
rapine (sdNVP) to 104 women, including 7 enrolled in
the TEmAA ANRS clinical trial who received AZT and both
sdNVP and Truvada® at the onset of labour. Six women
received AZT only, and 2 a single dose of NVP only.
Finally, 14 did not receive any antiretroviral interventions.
177 infants received a sdNVP and AZT twice a day for 7
days, 33 received a sdNVP and AZT for 1 month, 1
received sdNVP and AZT on delivery only, 2 only sdNVP
and 1 no treatment. Infant formula milk was provided to
214 mothers choosing the formula feeding option and 1
was exclusively breastfed. Nine out of 215 infants (4.2%)
were early diagnosed and confirmed HIV-1 infected
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before the age of 2 months. Two of them were born from
mothers receiving no therapy, 2 from mothers receiving
sdNVP only. One was on HAART and 4 received AZT.
Conclusion
The 4.2 % rate of MTCT of HIV-1 we report here confirms
the feasibility and effectiveness of a large-scale PMTCT
programme in an urban and sub urban settings.Page 2 of 2
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